跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
C1-esterase inhibitor
首页
药物
C1-esterase inhibitor
C1-esterase inhibitor
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICENCY
EP 3508213 A1
申请人: SHIRE VIROPHARMA INC
优先权: 2013
CN
EP
US
10 件公开
METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR
EP 4162947 A1
申请人: TAKEDA PHARMACEUTICALS CO
优先权: 2013
CN
EP
US
5 件公开
PROCESS FOR PURIFYING C1-INH
EP 3994165 A1
申请人: CSL BEHRING GMBH
优先权: 2019
CN
EP
US
WO
4 件公开
Method of reducing complement - mediated disruption of cells
US 7264922 B2
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2005
US
4 件公开
PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
EP 3493832 A1
申请人: CSL BEHRING GMBH
优先权: 2016
CN
EP
US
3 件公开
CN 107257683 A
申请人: CSL BEHRING GMBH
优先权: 2015
CN
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEREDITARY ANGIOEDEMA
EP 4196172 A2
申请人: ORCHARD THERAPEUTICS EUROPE LTD
优先权: 2020
EP
US
WO
3 件公开
C1-esterase inhibitor preparation
US 12083171 B2
申请人: OCTAPHARMA AG
优先权: 2017
CN
US
3 件公开
C1 ESTERASE INHIBITOR FUSION PROTEINS AND USES THEREOF
EP 3769780 A1
申请人: SHIRE HUMAN GENETIC THERAPIES
优先权: 2014
CN
EP
2 件公开
CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF
US 20250170227 A1
申请人: TAKEDA PHARMACEUTICALS CO
优先权: 2016
CN
US
2 件公开
METHODS OF PREPARING ALBUMIN PREPARATIONS
US 20250223337 A1
申请人: CSL BEHRING LLC
优先权: 2022
CN
US
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈